A trial comparing two combinations of chemotherapy for clear cell ovarian cancer (CCC1)

Overview

Cancer types:

Ovarian cancer

Status:

Results

Phase:

Phase 3

Details

This trial compared paclitaxel and carboplatin with irinotecan and cisplatin for clear cell cancer, a rare form of ovarian cancer. Cancer Research UK supported this trial.

Recruitment start: 14 May 2010

Recruitment end: 7 February 2011

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr John Green

Supported by

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

NHS Greater Glasgow & Clyde

University of Glasgow

Other information

This is Cancer Research UK trial number CRUK/07/029.

Last reviewed: 11 Oct 2016

CRUK internal database number: 1708

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

Questions for your doctor

What to ask your doctor about clinical trials.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.